Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Signaling Elements Involved in the Metabolic Regulation of mTOR by Nutrients, Incretins, and Growth Factors in Islets

Kwon, Guim, Marshall, Connie A., Pappan, Kirk L., Remedi, Maria S., McDaniel, Michael L. · 2004 · Diabetes

Abstract

Mammalian target of rapamycin (mTOR) is a protein kinase that integrates signals from mitogens and the nutrients, glucose and amino acids, to regulate cellular growth and proliferation. Previous findings demonstrated that glucose robustly activates mTOR in an amino acid-dependent manner in rodent and human islets. Furthermore, activation of mTOR by glucose significantly increases rodent islet DNA synthesis that is abolished by rapamycin. Glucagon-like peptide-1 (GLP-1) agonists, through the production of cAMP, have been shown to enhance glucose-dependent proinsulin biosynthesis and secretion and to stimulate cellular growth and proliferation. The objective of this study was to determine if the glucose-dependent and cAMP-mediated mechanism by which GLP-1 agonists enhance β-cell growth and proliferation is mediated, in part, through mTOR. Our studies demonstrated that forskolin-generated cAMP resulted in activation of mTOR at basal glucose concentrations as assessed by phosphorylation of S6K1, a downstream effector of mTOR. Conversely, an adenylyl cyclase inhibitor partially blocked glucose-induced S6K1 phosphorylation. Furthermore, the GLP-1 receptor agonist, Exenatide, dose-dependently enhanced phosphorylation of S6K1 at an intermediate glucose concentration (8 mmol/l) in a rapamycin-sensitive manner. To determine the mechanism responsible for this potentiation of mTOR, the effects of intra- and extracellular Ca2+ were examined. Glyburide, an inhibitor of ATP-sensitive K+ channels (KATP channels), provided partial activation of mTOR at basal glucose concentrations due to the influx of extracellular Ca2+, and diazoxide, an activator of KATP channels, resulted in partial inhibition of S6K1 phosphorylation by 20 mmol/l glucose. Furthermore, Exenatide or forskolin reversed the inhibition by diazoxide, probably through mobilization of intracellular Ca2+ stores by cAMP. BAPTA, a chelator of intracellular Ca2+, resulted in inhibition of glucose-stimulated S6K1 phosphorylation due to a reduction in cytosolic Ca2+ concentrations. Selective blockade of glucose-stimulated Ca2+ influx unmasked a protein kinase A (PKA)-sensitive component involved in the mobilization of intracellular Ca2+ stores, as revealed with the PKA inhibitor H-89. Overall, these studies support our hypothesis that incretin-derived cAMP participates in the metabolic activation of mTOR by mobilizing intracellular Ca2+ stores that upregulate mitochondrial dehydrogenases and result in enhanced ATP production. ATP can then modulate KATP channels, serve as a substrate for adenylyl cyclase, and possibly directly regulate mTOR activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.53.suppl_3.s225

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 27

  1. Harris TE, Lawrence Jr JC: TOR signaling. Sci STKE 212:re15:1–17,2003 · DOI · Paper page
  2. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N: Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15:658–664,1996 · DOI · Paper page
  3. Meyuhas O: Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267:6321–6330,2000 · DOI · Paper page
  4. Lawrence JC Jr, Abraham RT: PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem Sci 22:345–349,1997 · DOI · Paper page
  5. Morley SJ: Intracellular signaling pathways regulating initiation factor eIF4E phosphorylation during the activation of cell growth. Biochem Soc Trans 25:503–509 · DOI
  6. Gingras AC, Raught B, Sonenberg N: eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963,1999 · DOI · Paper page
  7. Cutlar NS, Heitman J, Cardenas ME: TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals. Mol Cell Endocrinol 155:135–142,1999 · DOI
  8. McDaniel ML, Marshall CA, Pappan KL, Kwon GK: Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic β-cells. Diabetes 51:2877–2885,2002 · DOI
  9. Xu G, Marshall CA, Lin T-A, Kwon G, Munivenkatappa RB, Hill JR, Lawrence JC Jr, McDaniel ML: Insulin mediates glucose stimulated phosphorylation of PHAS-I by pancreatic β-cells: an insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem 273:4485–4491,1998 · DOI
  10. Xu G, Kwon G, Marshall CA, Lin T-A, Lawrence JC Jr, McDaniel ML: Branched-chain amino acids are essential in the regulation of PHAS-I and p70S6 kinase by pancreatic β-cells: a possible role in protein translation and mitogenic signaling. J Biol Chem 273:28178–28184,1998 · DOI · Paper page
  11. Xu G, Kwon G, Cruz WS, Marshall CA, McDaniel ML: Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic β-cells. Diabetes 50:353–360,2001 · DOI · Paper page
  12. Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G: Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408:994–997,2002 · DOI · Paper page
  13. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ: International Union of Pharmacology. XXXV. The Glucagon Receptor Family. Pharmacol Rev 55:167–194,2003 · DOI · Paper page
  14. Drucker DJ: Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17:161–171,2003 · DOI · Paper page
  15. Holz GG, Chepurny OG: Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. Curr Med Chem 10:2471–2483,2003 · DOI
  16. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270–2276,1999 · DOI · Paper page
  17. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B: Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443–1452,2002 · DOI · Paper page
  18. Leech CA, Holz GG, Chepurny O, Habener JF: Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic β-cells. Biochem Biophys Res Commun 278:44–47,2003 · DOI
  19. Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD: Effect of glycemic control of Exenatide (synthetic Exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care 26:2370–2377,2003 · DOI · Paper page
  20. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S: Critical role of cAMP-GEFII.Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276:46046–46053,2001 · DOI · Paper page
  21. Holz GG Leech CA, Heller RS, Castonguay M, Habener JF: cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic β-cells: a Ca2+ signaling system simulated by the insulinotropic hormone glucagon-like peptide-1 (7-37). J Biol Chem 274:14147–14156,1999 · DOI · Paper page
  22. Dunne MJ, Illot MC, Petterson OH: Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line. J Membr Biol 99:215–224,1987 · DOI
  23. Desai BN, Myers BR, Schreiber SL: FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A 99:4319–4324,2002 · DOI · Paper page
  24. Dennis PB, Jaesschke A, Saitoh M, Fowler B, Kozma SC, Thomas G: mTOR: a homeostatic ATP sensor. Science 294:1102–1105,2001 · DOI · Paper page
  25. Tsuboi T, Xavier GD, Holz GG, Jouaville LS, Thomas AP, Rutter GA: Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 β-cells. Biochem J 369:287–299,2003 · DOI · Paper page
  26. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ: Differential activation mechanisms of erk-1/2 and p70s6k by glucose in pancreatic β-cells. Diabetes 52:974–983,2003 · DOI · Paper page
  27. Kwon GK, Pappan KL, Marshall CA, Schaffer JE, McDaniel ML: Cyclic AMP dose-dependently prevents palmitate-induced apoptosis by both PKA- and cAMP-GEF-dependent pathways in β-cells. J Biol Chem 279:8938–8945,2004 · DOI

Cited by

See all 170

Metadata

Authors
Kwon, G., Marshall, C. A., Pappan, K. L., Remedi, M. S., & McDaniel, M. L.
Venue
Diabetes
Published
2004-12-01
Volume
53
Issue
suppl_3
Pages
S225-S232
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2126282353
Cited by
170
References
3
FWCI
4.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Signaling Elements Involved in the Metabolic Regulation of mTOR by Nutrients, Incretins, and Growth Factors in Islets. https://app.cochat.ai/papers/10.2337/diabetes.53.suppl_3.s225
The paper
Kwon, G., Marshall, C. A., Pappan, K. L., Remedi, M. S., & McDaniel, M. L. (2004). Signaling Elements Involved in the Metabolic Regulation of mTOR by Nutrients, Incretins, and Growth Factors in Islets. Diabetes. https://doi.org/10.2337/diabetes.53.suppl_3.s225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.